TY - JOUR
T1 - Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children
AU - for the Pediatric Emergency Research Network-COVID-19 Study Team
AU - Xie, Jianling
AU - Kuppermann, Nathan
AU - Florin, Todd A.
AU - Tancredi, Daniel J.
AU - Funk, Anna L.
AU - Kim, Kelly
AU - Salvadori, Marina I.
AU - Yock-Corrales, Adriana
AU - Shah, Nipam P.
AU - Breslin, Kristen A.
AU - Chaudhari, Pradip P.
AU - Bergmann, Kelly R.
AU - Ahmad, Fahd A.
AU - Nebhrajani, Jasmine R.
AU - Mintegi, Santiago
AU - Gangoiti, Iker
AU - Plint, Amy C.
AU - Avva, Usha R.
AU - Gardiner, Michael A.
AU - Malley, Richard
AU - Finkelstein, Yaron
AU - Dalziel, Stuart R.
AU - Bhatt, Maala
AU - Kannikeswaran, Nirupama
AU - Caperell, Kerry
AU - Campos, Carmen
AU - Sabhaney, Vikram J.
AU - Chong, Shu Ling
AU - Lunoe, Maren M.
AU - Rogers, Alexander J.
AU - Becker, Sarah M.
AU - Borland, Meredith L.
AU - Sartori, Laura F.
AU - Pavlicich, Viviana
AU - Rino, Pedro B.
AU - Morrison, Andrea K.
AU - Neuman, Mark I.
AU - Poonai, Naveen
AU - Simon, Norma Jean E.
AU - Kam, April J.
AU - Kwok, Maria Y.
AU - Morris, Claudia R.
AU - Palumbo, Laura
AU - Ambroggio, Lilliam
AU - Navanandan, Nidhya
AU - Eckerle, Michelle
AU - Klassen, Terry P.
AU - Payne, Daniel C.
AU - Cherry, Jonathan C.
AU - Waseem, Muhammad
AU - Dixon, Andrew C.
AU - Ferre, Isabel Beneyto
AU - Freedman, Stephen B.
N1 - Funding Information:
Financial support. This study was supported by grants from the Canadian Institutes of Health Research (Operating Grant: COVID-19—Clinical management; S.F.), the Alberta Health Service—University of Calgary—Clinical Research Fund (S.F.), the Alberta Children's Hospital Research Institute (S.F.), the COVID-19 Research Accelerator Funding Track (CRAFT) Program at the University of California, Davis (N.K.), and the Cincinnati Children's Hospital Medical Center Division of Emergency Medicine Small Grants Program (T.F.). Dr. Anna Funk was supported by the University of Calgary Eyes-High Post-Doctoral Research Fund. Dr. Stephen Freedman is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness. Dr. Stuart Dalziel was partially supported by Cure Kids New Zealand.
Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Background. To assist clinicians with identifying children at risk of severe outcomes, we assessed the association between laboratory findings and severe outcomes among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–infected children and determined if SARS-CoV-2 test result status modified the associations. Methods. We conducted a cross-sectional analysis of participants tested for SARS-CoV-2 infection in 41 pediatric emergency departments in 10 countries. Participants were hospitalized, had laboratory testing performed, and completed 14-day follow-up. The primary objective was to assess the associations between laboratory findings and severe outcomes. The secondary objective was to determine if the SARS-CoV-2 test result modified the associations. Results. We included 1817 participants; 522 (28.7%) SARS-CoV-2 test-positive and 1295 (71.3%) test-negative. Seventy-five (14.4%) test-positive and 174 (13.4%) test-negative children experienced severe outcomes. In regression analysis, we found that among SARS-CoV-2-positive children, procalcitonin ≥0.5 ng/mL (adjusted odds ratio [aOR], 9.14; 95% CI, 2.90–28.80), ferritin >500 ng/mL (aOR, 7.95; 95% CI, 1.89–33.44), D-dimer ≥1500 ng/mL (aOR, 4.57; 95% CI, 1.12–18.68), serum glucose ≥120 mg/dL (aOR, 2.01; 95% CI, 1.06–3.81), lymphocyte count <1.0 × 109/L (aOR, 3.21; 95% CI, 1.34–7.69), and platelet count <150 × 109/L (aOR, 2.82; 95% CI, 1.31–6.07) were associated with severe outcomes. Evaluation of the interaction term revealed that a positive SARS-CoV-2 result increased the associations with severe outcomes for elevated procalcitonin, C-reactive protein (CRP), D-dimer, and for reduced lymphocyte and platelet counts. Conclusions. Specific laboratory parameters are associated with severe outcomes in SARS-CoV-2-infected children, and elevated serum procalcitonin, CRP, and D-dimer and low absolute lymphocyte and platelet counts were more strongly associated with severe outcomes in children testing positive compared with those testing negative.
AB - Background. To assist clinicians with identifying children at risk of severe outcomes, we assessed the association between laboratory findings and severe outcomes among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–infected children and determined if SARS-CoV-2 test result status modified the associations. Methods. We conducted a cross-sectional analysis of participants tested for SARS-CoV-2 infection in 41 pediatric emergency departments in 10 countries. Participants were hospitalized, had laboratory testing performed, and completed 14-day follow-up. The primary objective was to assess the associations between laboratory findings and severe outcomes. The secondary objective was to determine if the SARS-CoV-2 test result modified the associations. Results. We included 1817 participants; 522 (28.7%) SARS-CoV-2 test-positive and 1295 (71.3%) test-negative. Seventy-five (14.4%) test-positive and 174 (13.4%) test-negative children experienced severe outcomes. In regression analysis, we found that among SARS-CoV-2-positive children, procalcitonin ≥0.5 ng/mL (adjusted odds ratio [aOR], 9.14; 95% CI, 2.90–28.80), ferritin >500 ng/mL (aOR, 7.95; 95% CI, 1.89–33.44), D-dimer ≥1500 ng/mL (aOR, 4.57; 95% CI, 1.12–18.68), serum glucose ≥120 mg/dL (aOR, 2.01; 95% CI, 1.06–3.81), lymphocyte count <1.0 × 109/L (aOR, 3.21; 95% CI, 1.34–7.69), and platelet count <150 × 109/L (aOR, 2.82; 95% CI, 1.31–6.07) were associated with severe outcomes. Evaluation of the interaction term revealed that a positive SARS-CoV-2 result increased the associations with severe outcomes for elevated procalcitonin, C-reactive protein (CRP), D-dimer, and for reduced lymphocyte and platelet counts. Conclusions. Specific laboratory parameters are associated with severe outcomes in SARS-CoV-2-infected children, and elevated serum procalcitonin, CRP, and D-dimer and low absolute lymphocyte and platelet counts were more strongly associated with severe outcomes in children testing positive compared with those testing negative.
KW - C-reactive protein
KW - child
KW - COVID-19
KW - lymphopenia
KW - procalcitonin
KW - SARS-CoV-2
UR - https://www.scopus.com/pages/publications/85176293480
U2 - 10.1093/ofid/ofad485
DO - 10.1093/ofid/ofad485
M3 - Article
C2 - 37869403
AN - SCOPUS:85176293480
SN - 2328-8957
VL - 10
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 10
M1 - ofad485
ER -